Clomipramine-induced mania in unipolar depression

Area of Science:

• Psychiatry
• Neuroscience
• Pharmacology

Background:

• Unipolar depression is a common mood disorder.
• Antidepressant medications are a primary treatment for depression.
• The switch from depression to mania is a known but infrequent complication of antidepressant treatment.

Purpose of the Study:

• To investigate the incidence of manic behavior in patients with unipolar depression treated with clomipramine versus amitriptyline.
• To explore potential correlations between patient characteristics and the occurrence of treatment-emergent mania.

Main Methods:

• Randomized assignment of 50 hospitalized unipolar depressed patients to receive either clomipramine or amitriptyline.
• Monitoring patients for the development of manic behavior during treatment.
• Statistical analysis to identify correlations between treatment, patient age, and manic episode characteristics.

Main Results:

• Seven out of 50 patients developed manic behavior.
• Six of 25 patients treated with clomipramine became manic, compared to one of 25 treated with amitriptyline.
• The mean age of manic switch was 63, which is later than typically observed.

Conclusions:

• Clomipramine may be associated with a higher risk of inducing manic episodes in older unipolar depressed patients compared to amitriptyline.
• The switch into mania may be linked to clomipramine's effects on central dopamine and serotonin systems.
• Further research is warranted to understand the mechanisms and risk factors for treatment-emergent mania.